Small Cap Feast

17th June 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 



Delistings: 

Asian Energy Impact Trust (AEIP.L) has left the premium segment of the Main Market of the LSE. 
Horizonte Minerals (HZM.L) has left AIM.



Whats baking in the oven?

Potential**** Initial Public Offerings:

ITF announced:

4th June: Advanced Oxygen Therapy Inc (AOTI): The medical technology group with a proprietary therapy for the reduction in hospitalisations and amputations caused by non-healing wounds, particularly diabetic foot ulcers, announces its Schedule One and expected first day of trading on the AIM market of the 18th June. The Group expects to raise $25m.

Media speculation: (We remove rumours after 10 days of being on the menu)


Reverse Takeovers:


Change of Market:

Dual Listing :


Banquet Buffet

Corcel 0.12p £2.6m (CRCL.L)

The pan Angola-Brazil focused exploration and production Company announces that it has raised gross proceeds of £500,000 at 0.1p per share with high-net-worth investors. The fund will be primarily used to finance its ongoing working capital requirements and operations including geological and geophysical work in Angola and implementation of its business development initiatives in Brazil.

Cornish Metals 6.9p £34.8m (CUSN.L)

The mineral exploration and development Company focusing on advancing the South Crofty tin project and exploring its additional mineral rights today announces that it has entered into a binding letter of intent with Northera Resources Ltd. for the sale of the Company's 100% interest in the Nickel King and Opescal Lake properties for a total consideration of up to C$8m. The transaction includes the non-refundable cash payment to Cornish with C$1m in total and common shares of Northera with value of C$7m received by Cornish. The Company is expected to focus on advancing its 100% owned and fully permitted South Crofty tin project in the UK by selling the business in Nickel King, but will still retain the interest in pursuing the potential success in the area.

Eco Buildings Group 15.0p £9.2m (ECOB.L)

The modular housing Company, after a lengthy process of innovation and equipment and software upgrades, announces that it has now achieved fully automated production at its Albanian facility. Production time has been reduced by 33% thus increasing operating efficiency. A single production line is now capable of producing over 177,000 sqm of GFRG glass fibre reinforced gypsum walls per year - enough to deliver 768 houses a year based on a standard 60sqm two story flat roof detached house plan. These improvements have been achieved through incorporating new technology into the production process and a rigorous engineering overhaul of every component.

Keffi Gold and Copper 0.65p £38.2m (KEFI.L)

The gold and copper exploration and development Company focused on the Arabian-Nubian Shield and the Kingdom of Saudi Arabia announces its audited financial results for the year ended 31 December 2023. The loss before tax was £7.9m (2022: £6.4m) and the cash position was £0.2m. The Company is currently focused on completing the Early Works at Tulu Kapi so that the $320m project finance package could be closed and Major Works can be launched in October 2024. The Company expects to be a leader in the Arabian-Nubian Shield though the successful completion of the program with holdings in three production assets coming on stream in sequence from 2026.

Landore Resources 5p £6.7m (LND.L)

The exploration/development Company that seeks the acquisition, exploration and development of precious, base and battery metals projects in eastern Canada announces the Company's audited final results for the year to 31 December 2023. The loss after tax was £1,497,453 (2022: £1,860,585), and cash and cash equivalents was 564,682 (2022:1,235,528). Landore is planning to focus on advancing its highly prospective BAM Gold project, targeting a two-million-ounce resource whilst also completing a pre-feasibility study in 2024.

Lexington Gold 4.5p £17.6m (LEX.L)

The gold exploration and development Company with projects in South Africa and the USA today announce assay results from the recent gold exploration drill programme at its Jennings-Pioneer Project, located in South Carolina, USA. Assay results from 495m of drill core from three drill holes confirm the along strike and down plunge continuation of the Barite Hill Trend gold mineralisation onto the Jennings-Pioneer Project. All three target zones of Barite Hill trend were successfully targeted. And the massive sulphides, semi-massive sulphides and associated quartz barite veins were found in all three holes.

Longboat Energy 9.5P £4.1m (LBE.L)

The emerging E&P Company, today announces the agreement reached to sell its 50.1% holding in Longboat Japex Norge AS to its joint venture partner Japan Petroleum Exploration and the strategic pivot of the business to focus on Southeast Asia following the sale. The Company sell its interest in LJN to JAPEX for a cash consideration of $2.5m plus Longboat's share of drawn debt under the JAPEX Acquisition Facility. The board and management of Longboat Energy have decided to exit Norway and to focus on building a full-cycle E&P business in Southeast Asia, seeing more potential in Southeast Asia due to the structural change in the Norwegian upstream industry. The sale proceeds of the Company would provide working capital to run the Company through to the end of Q1-25 and cost savings in excess of $1.25m achieved with a streamlined board and management team.

Mind Gym 35p £38.6m (MIND.L)

The global provider of human capital and business improvement solutions announces its audited results for the year ended 31 March 2024. Revenue was £44.9m with a 18% decrease compared to last year (2022: £55m) and the loss before tax is £12.1m, a 502% decrease (2022: £3.0m profit). The loss can be attributed to confidence in its key sectors due to macroeconomic headwinds, increased caution on HR budget, increased competition for client budgets and the material decline in client spend on Diversity, Equity and Inclusion. Cash was £1.4m (FY22: £1.2m). MindGym is expected to return to its historic performance levels in FY25 by implementing the new strategy for growth. In the medium-term, the Board is therefore confident that the business will deliver revenue growth in excess of 10% CAGR, with EBITDA margins between 15% and 20%.

The Mission Group 25p £22.1m (TMG.L)

The collective of Agencies dedicated to helping Clients thrive today provides a trading update for the period 3 April 2024 to 17 June 2024. Trading in the period has continued in line with the Board's expectations. The Group reports further new business wins underpinned by the investments made in previous years to enhance Mission's service offering and capabilities. The Group is committed in its focus on debt reduction, rebuilding the balance sheet and delivering on its strategy for 2024 and 2025.

ValiRx 2.9p £3.4m (VAL.L)

The life science Company focusing on early-stage cancer therapeutics and women's health confirms the execution of a revenue-bearing contract for the provision of Patient Derived Cell based services with a new client. The contract is a multi-stage project and includes analysis and provision of RNA data, acquired as part of the scientific package from Imagen Therapeutics, in addition to bespoke cell-based screening in the laboratory. This initial phase of work will commence immediately, and the project is structured to build a long term working relationship with the client with scope to include potential future material revenue generation. The contract won is expected to be a significant step for the Company to establish the brand into other geographical markets.

.

17 June 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram